News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
MerLion Pharmaceuticals Pte Ltd Announces Sir Richard Sykes As New Chairman Of The Board Of Directors
February 14, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MerLion Pharmaceuticals Pte Ltd (MerLion) the Singapore-based natural products drug discovery company, announces the appointment of Sir Richard B. Sykes DSc. FRS as Chairman of its Board of Directors.
Twitter
LinkedIn
Facebook
Email
Print
People
Europe
MORE ON THIS TOPIC
Podcast
Gilead’s Ouro Buy, J&J/Protagonist’s Approval, Aurinia’s Revamp, ACIP Confusion, More
March 25, 2026
·
1 min read
·
Heather McKenzie
Manufacturing
Novartis Pledges $480M To Expand China Presence, Following Eli Lilly and AstraZeneca
March 24, 2026
·
2 min read
·
Nick Paul Taylor
People
Gilead Chief Gets 20% Pay Bump, Still Falls Short of $30M Club
March 24, 2026
·
2 min read
·
Tristan Manalac
Opinion
Biotechs Must Face Reality To Succeed in Today’s Funding Environment
March 24, 2026
·
5 min read
·
Ali Pashazadeh
